IOVA — IOVANCE BIOTHERAPEUTICS, INC.
Materials · Biological Products, (No Diagnostic Substances) · Nasdaq
3Insiders filing
9Transactions
+$0Reported buys
−$204kReported sells
0Cluster events
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| Vogt Frederick G | Interim CEO & General Counsel | 3 | $147k |
| BILINSKY IGOR | Chief Operating Officer | 3 | $37k |
| Puri Raj K. | Chief Regulatory Officer | 3 | $21k |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-01 | IOVA | Vogt Frederick G Interim CEO & General Counsel | M routine | 41,669 | — | — | |
| 2026-09-03 | 2026-09-01 | IOVA | Vogt Frederick G Interim CEO & General Counsel | F routine | 17,702 | $8.28 | −$147k | |
| 2026-09-03 | 2026-09-01 | IOVA | Vogt Frederick G Interim CEO & General Counsel | M routine | 41,669 | — | — | |
| 2026-09-03 | 2026-09-01 | IOVA | Puri Raj K. Chief Regulatory Officer | M routine | 5,470 | — | — | |
| 2026-09-03 | 2026-09-01 | IOVA | Puri Raj K. Chief Regulatory Officer | F routine | 2,508 | $8.28 | −$21k | |
| 2026-09-03 | 2026-09-01 | IOVA | Puri Raj K. Chief Regulatory Officer | M routine | 5,470 | — | — | |
| 2026-09-03 | 2026-09-01 | IOVA | BILINSKY IGOR Chief Operating Officer | M routine | 8,789 | — | — | |
| 2026-09-03 | 2026-09-01 | IOVA | BILINSKY IGOR Chief Operating Officer | F routine | 4,472 | $8.28 | −$37k | |
| 2026-09-03 | 2026-09-01 | IOVA | BILINSKY IGOR Chief Operating Officer | M routine | 8,789 | — | — |
No transactions match these filters.